XWELL announces three-year CDC contract extension for Traveler-based Genomic Surveillance through 2027

XWELL, Inc.

CDC extends Traveler-based Genomic Surveillance Program contract with XWELL for three additional years through 2027.
Contract renewal continues partnership between XWELL and CDC; financial terms not disclosed.
Announcement made on March 5, 2025 via press release.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.